Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

  • Lane, C. A., Hardy, J. & Schott, J. M. Alzheimer’s disease. Eur. J. Neurol. 25, 59–70 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 17, 327–406 (2021).

  • 2020 Alzheimer’s disease facts and figures. Alzheimers Dement. https://doi.org/10.1002/alz.12068 (2020).

  • McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269 (2011).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shaw, L. M. et al. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease. Alzheimers…

  • Read more…